Is Henry Meds Good for GLP-1 Maintenance? Microdose Costs Compared

Last reviewed: August 31, 2026 Last updated: August 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Yes, with a caveat about commitment. Henry Meds is one of the few GLP-1 telehealth programs with genuine maintenance-stage options — oral semaglutide and dedicated microdose tiers — rather than just the flagship injectable at full dose. The caveat is how those tiers are sold: the lowest rates in our capture were attached to prepaid multi-month plans, and Henry's own terms say multi-month patients may have to pay out the remaining balance to leave early. Whether that structure fits maintenance — a stage where clinicians adjust or pause therapy based on how weight holds — is the real question this page answers.

What maintenance actually requires from a provider

Maintenance is the stage after goal weight, when a licensed clinician decides whether to continue, reduce, or stop therapy based on the patient's history and how weight responds. From a program-shopping standpoint that translates into four practical requirements: a lower-intensity option actually on the menu (microdose or oral tiers), pricing that doesn't punish a dose reduction, the flexibility to pause or stop without owing the rest of a term, and calendar-predictable billing. Eligibility, medication choice, dose, and ongoing treatment decisions remain the clinician's — a program can only make the logistics easier or harder.

Henry's maintenance menu, as captured

Two things to note. First, the attractive microdose rates are term rates: the $99/month oral figure is charged $297 per prepaid quarter, and the $149/month injectable figure required the 12-month prepaid plan — these are prepaid equivalents, never directly comparable to a month-to-month rate. Second, freshness: Henry's current public microdose page states pricing "varies by treatment plan and dosing" and "starts at $179/month" (accessed August 31, 2026), which does not match the July tier sheet one-for-one — so confirm the current microdose tier inside Henry's signup before relying on any figure here. Henry's checkout remains $0 until prescribed, which makes checking low-risk.

The 12-month maintenance math, like-for-like

Using the July-captured tiers and keeping commitments labeled, a full maintenance year works out as follows. All annualizations are our calculations.

Read plainly: at its July-captured tier, Henry's oral microdose was the lowest 12-month figure in this comparison — $360 less than the PlexusDx flat rate — and if that tier still holds at your signup, it is the value pick for a patient certain they will complete the year on an oral microdose. The PlexusDx protocol answers a different maintenance reality: at $129/month flat, month-to-month, a clinician-directed change in plan costs you nothing beyond the month you are in. Between them, Henry prices the commitment; PlexusDx prices the flexibility.

The cancellation terms that matter at this stage

Henry's cancellation FAQ says you can cancel at any time, but that on a multi-month plan "you may be required to pay out the rest of your balance" unless a provider approves a medical reason, and its terms commit prescribed patients to the full contract term (language confirmed on Henry's site, August 31, 2026). Maintenance is precisely the stage where plans change — doses drop, pauses happen, some patients stop entirely. A prepaid year is a bet that none of that occurs on your clinician's advice before month twelve.

Choose Henry Meds for maintenance if…

You want an oral microdose at the lowest captured cash rate, you are confident you'll complete the prepaid term, and the quarterly (rather than annual) prepay keeps your exposure acceptable. Its $0-until-prescribed evaluation also makes it easy to verify the current tier before committing.

Choose the PlexusDx Microdose GLP-1 Protocol if…

You want maintenance without a term: $129/month flat, calendar-month billing, no membership fee, no prepayment, consult, medication, and shipping included — so a clinician-directed change of course never collides with a prepaid balance. Details are on the Microdose GLP-1 Protocol page.

Methodology and freshness

Henry Meds tier figures come from PlexusDx's review of Henry's published program pages and a signup run to the order summary on July 20, 2026 (27 dated screenshots), published on PlexusDx vs Henry Meds. Henry's public microdose and treatment pages were re-checked on August 31, 2026, confirming the included-services, cancellation language, and a "starts at $179/month" statement that we flag above as a freshness conflict with the July tier sheet. PlexusDx rates were verified on our live product pages on August 31, 2026. Per-month equivalents of prepaid plans are our calculations and are labeled as prepaid throughout. Our provider index and comparison methodology live on the GLP-1 alternatives hub; Henry's full program is covered in our Henry Meds GLP-1 program overview.

Frequently Asked Questions

Does Henry Meds have a real maintenance or microdose option?

Yes. In our July 2026 capture Henry offered oral microdose semaglutide on prepaid 3-month cycles and an injectable microdose tier attached to its 12-month prepaid plan, alongside standard oral semaglutide. That is a broader maintenance menu than most injection-only programs, which simply continue the flagship dose at the flagship price.

How much does GLP-1 maintenance cost at Henry Meds?

At the July 20, 2026 capture, Henry's oral microdose worked out to $99/month charged as $297 per prepaid quarter, and its injectable microdose was advertised at $149/month on the 12-month prepaid plan. Henry's current page states pricing starts at $179/month and varies by plan and dosing, so verify the live microdose tier during its free evaluation before deciding.

Can I stop a Henry Meds multi-month plan early?

Henry's published policy allows cancellation at any time but warns that multi-month patients "may be required to pay out the rest of your balance" unless a provider approves a medical reason. Practically, that means a prepaid maintenance term is best suited to patients confident their clinician's plan won't change before the term ends.

Is a prepaid microdose plan or a flat monthly protocol better for maintenance?

It depends on how settled your plan is. A prepaid tier at a lower equivalent rate rewards patients who complete the term. A flat month-to-month protocol — such as the PlexusDx Microdose GLP-1 Protocol at $129/month — costs somewhat more over a full year than Henry's July-captured oral tier but leaves nothing at risk when a clinician adjusts, pauses, or ends therapy.

Who decides whether I should move to a maintenance dose?

A licensed clinician. Eligibility, medication choice, dose, and ongoing treatment decisions are made by a licensed clinician based on the patient's medical history and clinical circumstances. Provider programs differ in logistics and price, but none of the options on this page change who makes the clinical decision.

Sources

• PlexusDx vs Henry Meds — checkout-verified comparison (captured July 20, 2026)
• Henry Meds public treatment and microdose pages, henrymeds.com (accessed August 31, 2026)
• PlexusDx Microdose GLP-1 Protocol (accessed August 31, 2026)
• Henry Meds GLP-1 program overview — PlexusDx Learn
• PlexusDx GLP-1 alternatives hub — methodology and provider index

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies. Eligibility, medication choice, dose, and ongoing treatment decisions are made by a licensed clinician based on the patient's medical history and clinical circumstances.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.